INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
$35.825 -0.145 (-0.4031%)
Analysed INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) News Sources
This Pharma Stock Eyes Entry As Opioid Addiction Specialist's Profits Surge 108%
31-07-2026
yahoo.com
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
03-08-2026
yahoo.com
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
03-08-2026
yahoo.com
Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
03-08-2026
yahoo.com
Supernus jumps premarket on merger deal; GameStop drops
03-08-2026
yahoo.com
Indivior Q2 Earnings Call Highlights
03-08-2026
marketbeat.com
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
04-08-2026
yahoo.com
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
21-08-2026
yahoo.com
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
21-08-2026
yahoo.com
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
22-08-2026
yahoo.com
What is the current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is $35.825.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is $-0.145.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is -0.4031%.
What is the most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is .
SEC-8K** Filing Available For INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.